Skip header and navigation

2 records – page 1 of 1.

Controversies in Cardiology

https://libcat.nshealth.ca/en/permalink/provcat39363
John A. Ambrose, Alfredo E. Rodr┬ęguez, editors. (1st ed.) --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiol…
Available Online
View e-Book
Other Authors
Ambrose, John A
Rodr┬ęguez, Alfredo E
Responsibility
John A. Ambrose, Alfredo E. Rodr©guez, editors
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xviii, 417 p. : 53 illus., 41 illus. in color)
ISBN
9783319204154
9783319204147 (print ed.)
Subjects (MeSH)
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - therapy
Abstract
This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients.
Contents
[publisher supplied] Part I. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Part II. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women: evaluation and management -- Part III. Cardiovascular management -- Myocardial infarction and "normal" coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease: PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes: does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly: can or should we limit access? -- Cost benefits of TAVR: should the indications be expanded?
Format
e-Book
Location
Online
Less detail

Kawasaki Disease : Current Understanding of the Mechanism and Evidence-Based Treatment

https://libcat.nshealth.ca/en/permalink/provcat41918
Ben Tsutomu Saji, Jane W. Newburger, Jane C. Burns, Masato Takahashi, editors. --Tokyo: Springer , 2017.
Available Online
View e-Book
Location
Online
This book provides the most up-to-date information on the clinical research into and medical management of Kawasaki Disease, and opens the door for new pathological insights. Its nearly 50 sections cover basic research, genetic backgrounds, bacterial and biological evidence, and medical treatment with intravenous immunoglobulin, steroids, and recent anti-cytokine approaches. It offers an invaluable resource for general pediatricians, pediatric and adult cardiologists, pediatric cardiac surgeons…
Available Online
View e-Book
Other Authors
Saji, Ben Tsutomu
Newburger, Jane W
Burns, Jane C
Takahashi, Masato
Responsibility
Ben Tsutomu Saji, Jane W. Newburger, Jane C. Burns, Masato Takahashi, editors
Place of Publication
Tokyo
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (xix, 552 pages) : 77 illus., 38 illus. in color
ISBN
9784431560395
9784431560371 (print ed.)
Subjects (MeSH)
Mucocutaneous Lymph Node Syndrome - physiopathology
Mucocutaneous Lymph Node Syndrome - therapy
Abstract
This book provides the most up-to-date information on the clinical research into and medical management of Kawasaki Disease, and opens the door for new pathological insights. Its nearly 50 sections cover basic research, genetic backgrounds, bacterial and biological evidence, and medical treatment with intravenous immunoglobulin, steroids, and recent anti-cytokine approaches. It offers an invaluable resource for general pediatricians, pediatric and adult cardiologists, pediatric cardiac surgeons, infectious disease specialists, pediatric rheumatologists, epidemiologists, and basic researchers in these disciplines.
Contents
Part I: Basic Research -- 1. The History of Kawasaki Disease: A Personal Perspective -- 2. Histopathology of coronary arteritis in acute Kawasaki disease and murine systemic vasculitis induced by Candida albicans cell wall polysaccharide -- 3. Histopathological characteristics aspects of organs other than the heart of noncardiac organs in Kawasaki disease -- 4. Identification of Novel Kawasaki Disease Susceptibility Genes by Genome-Wide Association Studies -- 5. Immunological Abnormalities and Use of Biomarkers and Cytokines to Predict the Severity of Kawasaki Disease -- 6. Pathophysiology of Kawasaki Disease -- 7. Update on Pathogenesis: Lessons Learned from Animal Models of Disease -- 8. The climate-KD link -- 9. Kawasaki Disease Shock Syndrome -- 10. Future directions in Kawasaki disease research -- Part II: Epidemiology -- 11. Epidemiologic Perspectives -- 12. Update on nationwide surveys and epidemiologic characteristics of Kawasaki disease in Japan -- 13. Kawasaki Disease Epidemiology in Europe -- 14. Recent topics in the epidemiology of Kawasaki disease -- Part III: Diagnosis and Examinations -- 15. Overview of Medical Treatment -- 16. Overview of the New Japanese Guideline2012 for the Medical Treatment of Acute Stage of Kawasaki Disease -- 17. Tumor Necrosis Factor- Blockade for Treatment of Acute Kawasaki Disease -- 18. Methylprednisolone Pulse Therapy for Nonresponders to Immunoglobulin Therapy -- 19. Prednisolone -- 20. Cyclosporin A for IVIG nonresponders -- 21. Other challenging therapies -- 22. Antiplatelet and Antithrombotic Therapy for Giant Coronary Aneurysm -- 23. Characteristics of Sudden Cardiac Death Late After Acute Kawasaki Disease -- 24. Kawasaki disease diagnosis and complication rates in the United States and Japan -- 25. Mechanism of Action of Immunoglobulin: Sialylated IgG -- 26. Treatment Options for Refractory Kawasaki Disease: Alternative Treatments for Infliximab Nonresponders -- 27. Ulinastatin -- 28. Diagnosis and Management of Cardiovascular Risk Factors -- 29. Diagnosis and Characteristics of Typical and Incomplete Kawasaki Disease -- 30. Scoring systems to predict coronary artery lesions and nonresponse to initial intravenous immunoglobulin therapy -- 31. Use of magnetic resonance angiography for assessment of coronary artery lesions caused by Kawasaki disease -- 32. CT coronary and myocardial images in patients with coronary artery lesions -- 33. Long-Term Follow-up and Education Regarding Daily Life Activities, School Life, and Guidelines After Acute KD -- 34. Assessment of cardiac ischemia during acute and long-term follow-up and rheologic assessment of coronary artery lesions after Kawasaki disease -- 35. Promising biomarkers in acute Kawasaki disease and acute coronary ischemia -- 36. Coronary artery diameter Z score calculator -- 37. Evidence of endothelial damage in acute KD -- 38. Oxidative Stress in Kawasaki Disease -- Part V: Catheter Intervention and Surgery -- 39. Antiplatelet and anticoagulant therapies for Kawasaki disease: theory and practice -- 40. Guidelines for catheter intervention for coronary artery lesions in Kawasaki disease -- 41. Long-term Clinical Follow-up After Rotational Atherectomy for Coronary Arterial Stenosis in Kawasaki Disease -- 42. Long-term outcomes of pediatric coronary artery bypass grafting and downsizing for giant coronary aneurysms -- 43. Long-term outcomes of pediatric coronary artery bypass grafting and downsizing for giant coronary aneurysms -- Part VI: Follow-up Concerns -- 44. Functional and structural alterations of coronary arteries late after Kawasaki disease and the risk of acute coronary syndrome in adults -- 45. Psychosocial Effects of Kawasaki Disease and Transition to Adult Care -- 46. Kawasaki Disease: Road Map for the Future -- Appendix: Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013).
Format
e-Book
Location
Online
Less detail